Methyl aminolaevulinate photodynamic therapy for Bowen's disease: A practical option?

Australasian Journal of Dermatology

Volumn 46, Issue SUPPL., 2005, Pages

  Morton, Colin A ^a  

^a Ward 17 Falkirk Community Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; FLUOROURACIL;

ACTINIC KERATOSIS; BOWEN DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CRYOTHERAPY; CURETTAGE; DRUG EFFICACY; ECZEMA; EROSION; HUMAN; INFECTION; PAIN; PHOTODYNAMIC THERAPY; RECURRENCE RISK; SIDE EFFECT; SKIN ULCER;

EID: 14244263569     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2005.ajd_metvix_p6.pdf.x-i1     Document Type: Conference Paper

References (5)

1. Thestrup-Pedersen K, Ravnborg L, Reymann F. Morbus Bowen. A description of the disease in 617 patients. Acta Dermato-Venereologica 1988; 68: 236-9.
2. Morton CA, Whitehurst C, Moseley H, McColl JH, Moore JV, Mackie RM. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br. J. Dermatol. 1996; 135: 766-71.
3. Salim A, Leman JA, McColl JH, Chapman R, Morton CA. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br. J. Dermatol. 2003; 148: 539-43.
4. Wiegell SR, Stender IM, Na R, Wulf HC. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch. Dermatol. 2003; 139: 1173-7.
5. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br. J. Dermatol. 2002; 146: 552-67.